Trial tests if tinkering with Parkinson's pill mix can stop dangerous dizziness
NCT ID NCT06831500
Summary
This study is a small, early-stage trial to see if it's possible to run a larger future study. It aims to find out if changing the mix of two ingredients (Carbidopa and Levodopa) in a common Parkinson's disease medication can better control sudden drops in blood pressure when standing up. The research will involve 36 people with either Parkinson's disease or a related condition called MSA-P who experience this dizziness and fainting risk.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire Vaudois
RECRUITINGLausanne, Canton of Vaud, 1012, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Hospitalier Universitaire Vaudois (CHUV)
RECRUITINGLausanne, Canton of Vaud, 1005, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.